Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Dec 13th 2019, Crypto Chartbook – Building positions, arriving at target loaded

Building positions, arriving at target loaded December markets are tricky. With the closing of the year come rollovers in futures markets, tax considerations, hedge fund portfolio allocations due to accountability and much more. Markets are a reflection of human behavior a...
Midas Touch Consulting | December 16, 2019 |

Buzz on the Bullboards: Stocks to watch in volatile times.

This week, Canada’s main stock index, the TSX , hit another record high, supported by strong retail sales data and positive investor sentiment. However, the index quickly fell from grace following U.S. President-elect Donald Trump’s announ...
Jonathon Brown | November 28, 2024 |

Assertio Therapeutics' Shares Jump 50% on Sale of Shingles Pain Drug to Alvogen

Assertio Therapeutics' shares rose 50% today after the firm reported that it has agreed to sell all rights to its Gralise drug used in the treatment of pain from shingles to Alvogen for $127.5 million. The transaction is expected to close in January 2020. Shares of ph...
Streetwise Reports | December 13, 2019 |

U.S.-Based Biotech 'Growing into a Giant with AI'

How Moderna uses and benefits from digitization and artificial intelligence are described in a ROTH Capital Partners report. In a March 5 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that a site visit to Moderna Inc.'s (MRNA:NASDAQ) ...
Streetwise Reports | March 9, 2020 |

Buzz on the Bullboards: Who benefits from the latest stock market rally?

It was a more nuanced performance for stock markets in Toronto and New York this week with notable gains and splits between indices capturing investor attention. The TSX surged to highs not seen in a month, buoyed by optimism, while in the United States, some stocks ...
Jonathon Brown | May 9, 2024 |

BASF and Cardiol Therapeutics recommended buys; TUI rides momentum

BASF (OTCQX:BASFY) shares have gained over 30% within six months. But is the rally in BASF shares slowly running out of steam? The fact that the stock did not rise sharply yesterday despite a significant price target increase suggests this is the case. Many experts see ...
Fabian Lorenz | April 10, 2024 |

Take a closer look at HelloFresh, Bayer and Altech Advanced Materials

Bayer shares gained around 7 per cent last week. Is this the turnaround after the stock reached a multi-year low? Altech Advanced Materials stock is also working on an upward trend. The German battery hopeful has published a promising feasibility study. Their stationary s...
Fabian Lorenz | April 5, 2024 |

Is China getting serious? Rheinmetall and Almonty Industries profit

Is China really preparing for an attack on Taiwan? It is well known that China is massively increasing its gold reserves. But why tungsten, too? After all, China itself is the largest producer of this raw material, which is not only in demand in the arms industry. ...
Fabian Lorenz | April 24, 2024 |

Stocks facing revaluation: Nel, Bayer, Power Nickel with potential

Relief for Bayer. In the U.S., the company has won a victory in the dispute over compensation for illnesses caused by the chemical PCB. Is it groundbreaking and the start of a revaluation of the stock? A revaluation already seems to be underway at Power Nickel. Follo...
Fabian Lorenz | May 9, 2024 |

BioNTech & Cardiol Therapeutics – on the verge of a breakout

Compared with the broader indices, DAX and Dow Jones, which have already reached new all-time highs, the Nasdaq Biotech Index is currently lagging. The sector index is still around 23% below its peak from August 2021. Nevertheless, the sector is on the move. In addition t...
Stefan Feulner | May 22, 2024 |
1 2 3 4 5 6 7